logo

Mannkind Corp. (MNKD)



Trade MNKD now with
  Date
  Headline
7/20/2020 9:23:48 AM MannKind Names Alejandro Galindo Chief Commercial Officer
3/17/2020 9:05:10 AM MannKind Adjusts R&D Resources In Response To COVID-19 Pandemic
2/25/2020 8:16:25 AM MannKind Q4 Loss Per Share $0.07 Vs Loss $0.06 Last Year
1/6/2020 8:15:54 AM MannKind Partner Biomm Receive Written Notice From CMED Approving Proposed Price Of Afrezza In Brazil
11/21/2019 9:09:13 AM MannKind Adds Tony Hooper To Its Board
9/19/2019 9:01:29 AM MannKind Presents Data From One-year Study Of Afrezza Inhalation Powder
1/16/2019 4:31:52 PM MannKind Announces Direct Purchase Insulin Program Providing Afrezza For As Low As $4 A Day
12/19/2018 11:58:54 PM MannKind Announces Pricing Of Public Offering Of 26.67 Mln Shares And Warrants For A Combined Purchase Price Of $1.50
11/1/2018 8:06:00 AM MannKind Q3 Net Loss $24.2 Mln Or $0.16/Shr Vs Loss $32.9 Mln Or $0.31/Shr Last Year